Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accent Pharma is a contract development and manufacturing organization (CDMO) and a proud member of the Madras Pharmaceuticals group. Established in 2005, the company operates a state-of-the-art manufacturing facility in Pondicherry, India, specializing in novel dosage forms for respiratory therapy and oral solid dosages. Its capabilities include the production of pressurized metered-dose inhalers (pMDIs), capsule-based dry powder inhalers (DPIs), multi-dose nasal sprays, nebulizing solutions, and oral solid dosages (tablets and capsules) across potent and steroidal categories. Accent Pharma serves as a trusted manufacturing partner for leading domestic and international pharmaceutical companies, delivering high-quality formulations that comply with WHO-GMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MS Accent Pharma.